Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 118

1.

Prostate cancer survival among statin users after prostatectomy in a Finnish nationwide cohort.

Joentausta RM, Rannikko A, Murtola TJ.

Prostate. 2019 May;79(6):583-591. doi: 10.1002/pros.23768. Epub 2019 Jan 16.

PMID:
30652328
2.

Antihypertensive drugs and prostate cancer survival after radical prostatectomy in Finland-A nationwide cohort study.

Santala EE, Rannikko A, Murtola TJ.

Int J Cancer. 2019 Feb 1;144(3):440-447. doi: 10.1002/ijc.31802. Epub 2018 Nov 5.

PMID:
30110124
3.

Statin Use and Prostate Cancer Survival in the Finnish Randomized Study of Screening for Prostate Cancer.

Murtola TJ, Peltomaa AI, Talala K, Määttänen L, Taari K, Tammela TLJ, Auvinen A.

Eur Urol Focus. 2017 Apr;3(2-3):212-220. doi: 10.1016/j.euf.2016.05.004. Epub 2016 Jun 2.

PMID:
28753762
4.

Associations between statin use and progression in men with prostate cancer treated with primary androgen deprivation therapy.

Mikkelsen MK, Thomsen FB, Berg KD, Jarden M, Larsen SB, Hansen RB, Brasso K.

Scand J Urol. 2017 Dec;51(6):464-469. doi: 10.1080/21681805.2017.1362032. Epub 2017 Aug 23.

PMID:
28831860
5.

Statin use and risk of disease recurrence and death after radical prostatectomy.

Keskiväli T, Kujala P, Visakorpi T, Tammela TL, Murtola TJ.

Prostate. 2016 Apr;76(5):469-78. doi: 10.1002/pros.23138. Epub 2015 Dec 22.

PMID:
26689439
6.

Statin Use at the Time of Initiation of Androgen Deprivation Therapy and Time to Progression in Patients With Hormone-Sensitive Prostate Cancer.

Harshman LC, Wang X, Nakabayashi M, Xie W, Valenca L, Werner L, Yu Y, Kantoff AM, Sweeney CJ, Mucci LA, Pomerantz M, Lee GS, Kantoff PW.

JAMA Oncol. 2015 Jul;1(4):495-504. doi: 10.1001/jamaoncol.2015.0829. Erratum in: JAMA Oncol. 2015 Jul;1(4):544.

7.

Serum Lipids Prior to Starting Androgen Deprivation Therapy and Risk of Castration-Resistant Prostate Cancer and Metastasis: Results from the SEARCH Database.

Dambal S, Howard LE, Allott EH, Aronson WJ, Kane CJ, Amling CL, Cooperberg MR, Terris MK, Freedland SJ.

J Urol. 2019 Aug 20:101097JU0000000000000494. doi: 10.1097/JU.0000000000000494. [Epub ahead of print]

PMID:
31430247
8.

Tumor features and survival after radical prostatectomy among antidiabetic drug users.

Joentausta RM, Kujala PM, Visakorpi T, Tammela TL, Murtola TJ.

Prostate Cancer Prostatic Dis. 2016 Dec;19(4):367-373. doi: 10.1038/pcan.2016.32. Epub 2016 Aug 9.

PMID:
27502739
9.

Prostate cancer and PSA among statin users in the Finnish prostate cancer screening trial.

Murtola TJ, Tammela TL, Määttänen L, Huhtala H, Platz EA, Ala-Opas M, Stenman UH, Auvinen A.

Int J Cancer. 2010 Oct 1;127(7):1650-9. doi: 10.1002/ijc.25165.

10.

EAU guidelines on prostate cancer. Part II: Treatment of advanced, relapsing, and castration-resistant prostate cancer.

Heidenreich A, Bastian PJ, Bellmunt J, Bolla M, Joniau S, van der Kwast T, Mason M, Matveev V, Wiegel T, Zattoni F, Mottet N; European Association of Urology.

Eur Urol. 2014 Feb;65(2):467-79. doi: 10.1016/j.eururo.2013.11.002. Epub 2013 Nov 12. Review.

PMID:
24321502
11.

Androgen deprivation therapy for localized prostate cancer and the risk of cardiovascular mortality.

Tsai HK, D'Amico AV, Sadetsky N, Chen MH, Carroll PR.

J Natl Cancer Inst. 2007 Oct 17;99(20):1516-24. Epub 2007 Oct 9.

PMID:
17925537
12.

Association between use of β-blockers and prostate cancer-specific survival: a cohort study of 3561 prostate cancer patients with high-risk or metastatic disease.

Grytli HH, Fagerland MW, Fosså SD, Taskén KA.

Eur Urol. 2014 Mar;65(3):635-41. doi: 10.1016/j.eururo.2013.01.007. Epub 2013 Jan 14.

PMID:
23351721
13.

Statin use and breast cancer survival: a nationwide cohort study from Finland.

Murtola TJ, Visvanathan K, Artama M, Vainio H, Pukkala E.

PLoS One. 2014 Oct 20;9(10):e110231. doi: 10.1371/journal.pone.0110231. eCollection 2014.

14.

The impact of statins in combination with androgen deprivation therapyin patients with advanced prostate cancer: A large observational study.

Anderson-Carter I, Posielski N, Liou JI, Khemees TA, Downs TM, Abel EJ, Jarrard DF, Richards KA.

Urol Oncol. 2019 Feb;37(2):130-137. doi: 10.1016/j.urolonc.2018.11.017. Epub 2018 Dec 7.

PMID:
30528885
15.

Use of Concomitant Androgen Deprivation Therapy in Patients Treated with Early Salvage Radiotherapy for Biochemical Recurrence After Radical Prostatectomy: Long-term Results from a Large, Multi-institutional Series.

Gandaglia G, Fossati N, Karnes RJ, Boorjian SA, Colicchia M, Bossi A, Seisen T, Cozzarini C, Di Muzio N, Noris Chiorda B, Zaffuto E, Wiegel T, Shariat SF, Goldner G, Joniau S, Battaglia A, Haustermans K, De Meerleer G, Fonteyne V, Ost P, Van Poppel H, Montorsi F, Briganti A.

Eur Urol. 2018 Apr;73(4):512-518. doi: 10.1016/j.eururo.2017.11.020. Epub 2017 Dec 8.

PMID:
29229176
16.

Duration of Androgen Deprivation Therapy Influences Outcomes for Patients Receiving Radiation Therapy Following Radical Prostatectomy.

Jackson WC, Schipper MJ, Johnson SB, Foster C, Li D, Sandler HM, Palapattu GS, Hamstra DA, Feng FY.

Eur Urol. 2016 Jan;69(1):50-7. doi: 10.1016/j.eururo.2015.05.009. Epub 2015 May 21.

PMID:
26004800
17.

Antidiabetic drug use and prostate cancer risk in the Finnish Randomized Study of Screening for Prostate Cancer.

Haring A, Murtola TJ, Talala K, Taari K, Tammela TL, Auvinen A.

Scand J Urol. 2017 Feb;51(1):5-12. doi: 10.1080/21681805.2016.1271353. Epub 2017 Jan 13.

PMID:
28084175
18.

Statin reduces the risk of dementia in diabetic patients receiving androgen deprivation therapy for prostate cancer.

Liu JM, Chen TH, Chuang HC, Wu CT, Hsu RJ.

Prostate Cancer Prostatic Dis. 2019 May;22(2):276-283. doi: 10.1038/s41391-018-0091-4. Epub 2018 Oct 18.

PMID:
30337635
19.

Prostate cancer-specific survival among warfarin users in the Finnish Randomized Study of Screening for Prostate Cancer.

Kinnunen PTT, Murtola TJ, Talala K, Taari K, Tammela TLJ, Auvinen A.

BMC Cancer. 2017 Aug 29;17(1):585. doi: 10.1186/s12885-017-3579-8.

20.

Mortality associated with statins in men with advanced prostate cancer treated with androgen deprivation therapy.

Wu SY, Fang SC, Shih HJ, Wen YC, Shao YJ.

Eur J Cancer. 2019 May;112:109-117. doi: 10.1016/j.ejca.2018.11.032. Epub 2019 Feb 28.

PMID:
30827745

Supplemental Content

Support Center